Drug discovery Archives

In Depth 7 Jun 2023

How Ireland connects AI and life sciences

Depending on your point of view, artificial intelligence (AI) can create jobs, make life easier, and solve many global problems; or, it’s going to cause mass unemployment, take over the…

June 7, 2023 - 7 minutesmins - By Jim Cornall

precision medicine, cancer, nRavel, Indivumed Therapeutics, early oncology discovery

Sponsored by

6 Jun 2023

Optimizing early discovery by unraveling cancer complexity within precision therapeutics

Precision medicine involves tailoring a therapeutic to a patients’ disease. Here, we delve into the critical role played by the quality of the samples, the data, and the analysis in…

June 6, 2023 - 7 minutesmins - By Sudha Sundaram

News and Trends 2 Jun 2023

Scientists develop probe to push for new drug discoveries

A study by Loughborough University and the University of Oxford in the U.K. has led to the development of a small molecule probe that could deepen the understanding of a…

June 2, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 31 May 2023

Artificial intelligence combats lethal superbug, new antibiotic discovered

A new antibiotic called abaucin that can kill a deadly, drug-resistant pathogen has been discovered with the help of artificial intelligence (AI). Research published in Nature Chemical Biology showed that…

May 31, 2023 - 3 minutesmins - By Roohi Mariam Peter

News and Trends 19 May 2023

Google Cloud adds AI solutions for drug discovery

Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead…

May 19, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 9 May 2023

Recursion boosts drug discovery with Cyclica and Valence acquisitions

Recursion has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica, for $40 million, and Valence, for $47.5 million. Chris Gibson, co-founder and CEO of Salt…

May 9, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 3 May 2023

First drug discovered through 3D bioprinted tissue disease model

Viscient Bio, Inc. has announced it has identified the world's first drug candidate discovered primarily using 3D bioprinted tissue models of disease formed from human cells. The company said it…

May 3, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 11 Apr 2023

PsychoGenics launches eCube AI platform for drug discovery

PsychoGenics Inc. has launched eCube, a pharmaco-electroencephalography (pharmacoEEG) platform to support phenotypic drug discovery. The company said that unlike traditional target-based drug discovery, this technique can identify novel treatments with…

April 11, 2023 - 3 minutesmins - By Jim Cornall

artificial intelligence AI drug discovery

News and Trends 9 Mar 2023

Iktos raises €15.5M to expand AI drug discovery technologies

Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a €15.5 million ($16.4 million) Series A financing co-led by new investors M Ventures and Debiopharm Innovation Fund…

March 9, 2023 - 2 minutesmins - By Jim Cornall

Sponsored by

21 Feb 2023

From breast to bone: Refining metastasis drug discovery with a novel organ-on-a-chip device

Understanding invasive cancer progression and metastasis formation are among the core open questions in cancer research. However, the limitations of current models lead to high failure rates in drug development.…

February 21, 2023 - 6 minutesmins - By Ute Boronowsky

MDI Biosciences Cardiff University. Photo/Cardiff University

News and Trends 14 Feb 2023

Astex and Cardiff University Medicines Discovery Institute to collaborate on neurodegenerative diseases

Astex Pharmaceuticals (UK), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system and The Medicines Discovery…

February 14, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 9 Feb 2023

Icosagen receives €18M loan for R&D and new facility

The Estonian biopharma company Icosagen AS has reached an €18 million financing agreement with the European Investment Bank (EIB) backed by the InvestEU program. The funds will strengthen the company’s…

February 9, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 2 Feb 2023

Possible drug targets from Korean atherosclerosis research

Research suggests that the enzyme phosphoenolpyruvate carboxykinase 2 (PCK2) and its gene play a role in the development of vascular injury and atherosclerosis. Atherosclerosis is a deadly disease; research suggests…

February 2, 2023 - 3 minutesmins - By Jim Cornall

Opinion 1 Feb 2023

Computational chemistry and cancer

by Martin Slater, Cresset Discovery Computational chemistry offers a fast and innovative approach to drug discovery and is especially powerful when used in combination with biological testing to provide a…

February 1, 2023 - 3 minutesmins - By External Contributor

cancer cell screening drug discovery microplate

Sponsored by

24 Jan 2023

Cancer cell line screening: a compass for drug discovery

Large-panel cancer cell line screening can help find the right fit between a specific cancer cell and a therapeutic molecule, leading to the development of effective treatments. How can robust…

January 24, 2023 - 5 minutesmins - By Alexander Burik

Interview 19 Jan 2023

Interview: Proscia talks about digital pathology

Labiotech recently interviewed Nathan Buchbinder, chief product officer at Proscia, about digital pathology. AI has been a hot topic in drug discovery. Can you outline how it’s being applied to…

January 19, 2023 - 8 minutesmins - By Jim Cornall

News and Trends 12 Jan 2023

Collaboration to boost pandemic preparedness, structure-based drug discovery and vaccine design

A new Memorandum of Understanding (MoU) to facilitate collaboration in the field of pandemic preparedness and to promote further cooperation between the University of Oxford and Diamond Light Source has…

January 12, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 11 Jan 2023

We DUB this target ‘druggable’

By Sheelagh Frame, CSO at Ubiquigent Modulation of the ubiquitin-proteasome system (UPS) presents a rich source for drug discovery. Recent years have seen the clinical validation of proteolysis-targeting chimeras (PROTACs)…

January 11, 2023 - 5 minutesmins - By External Contributor

News and Trends 20 Dec 2022

Watch: Interview with IRBM’s Heidi Kingdon Jones

The IRBM Group is an innovative research and discovery CRO (contract research organization) working across all aspects of drug discovery and early development. Headquartered in Italy, the company fosters collaborations…

December 20, 2022 - 1 minutemin - By Jim Cornall

Sponsored by

20 Dec 2022

Diving deep into science: How the life science industry relies on CRO’s drug hunter skills

Over the years, CROs have evolved from a transactional ‘pair of hands’ to organizations that are true partners in their client’s drug discovery journey, providing them with cutting edge science…

December 20, 2022 - 7 minutesmins - By Omnia Ibrahim

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Outsourcing in life science R&D today

Are you out-licensing?

Looking to expand your network?

Subscribe to our newsletter to get the latest biotech news!